NSE:BIOFILCHEM Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	27.86	5.58	7.09	5.6	6.98
Depreciation & Amortization	2.72	3.8	3.99	4.29	4.28
Other Operating Activities	0.07	0.58	2.34	-0.54	0.51
Change in Accounts Receivable	107.29	-52.86	-125.26	-133.29	100.44
Change in Inventory	-6.58	-7.92	-13.36	0.8	30.51
Change in Accounts Payable	-139.27	34.33	149.05	120.54	-152.56
Change in Other Net Operating Assets	1.87	-2.74	0.09	1.48	7.64
Operating Cash Flow	-6.05	-19.24	23.94	-1.12	-2.2
Capital Expenditures	-2.01	-1	-0.23	-0.11	-0.7
Sale of Property, Plant & Equipment	13.38	-	-	-	-
Investing Cash Flow	11.37	-1	-0.23	-0.11	-0.7
Long-Term Debt Issued	25.49	0.32	-	0.58	0.35
Total Debt Issued	25.49	0.32	-	0.58	0.35
Long-Term Debt Repaid	-	-	-0.83	-	-
Total Debt Repaid	-	-	-0.83	-	-
Net Debt Issued (Repaid)	25.49	0.32	-0.83	0.58	0.35
Other Financing Activities	-0.1	-0.37	-0.42	-0.43	-0.41
Financing Cash Flow	25.39	-0.05	-1.25	0.15	-0.06
Miscellaneous Cash Flow Adjustments	-	0	-	-	-
Net Cash Flow	30.71	-20.28	22.46	-1.07	-2.96
Free Cash Flow	-8.05	-20.24	23.71	-1.22	-2.9
Free Cash Flow Margin	-2.56%	-6.03%	5.87%	-0.41%	-1.29%
Free Cash Flow Per Share	-0.49	-1.24	1.46	-0.07	-0.18
Cash Interest Paid	0.1	0.36	0.4	0.42	0.39
Cash Income Tax Paid	4.07	2.1	2.4	2.3	2.71
Levered Free Cash Flow	-17.18	-21.71	19.89	-0.62	-4.6
Unlevered Free Cash Flow	-17.11	-21.48	20.14	-0.36	-4.36
Change in Working Capital	-36.7	-29.19	10.52	-10.47	-13.97